InsidersTradesSigma
디오 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 디오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 디오 has recorded 1 public disclosures. Market capitalisation: €145.6bn. The latest transaction was disclosed on 2 April 2026 (Purchase). Among the most active insiders: 디오홀딩스. All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,855 of 28,169 companies
38.1
score / 100
Value38
Quality38
FCF yld8.0%
Earn yld-0.9%
EV/EBITDA32.3x
ROE4.1%
Gross mgn67%
Net mgn-0.8%
Debt/EBITDA11.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 April 2026
About 디오
디오 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.